Cardiac Involvement in Miscellaneous Systemic Diseases

Key points
- The heart may be involved in a number of systemic syndromes.
- The most common type of myocardial involvement is an infiltrative cardiomyopathy, such as systemic amyloidosis, sarcoidosis, hemochromatosis, or glycogen storage disease.
- In addition to left ventricular dysfunction and heart failure, all of these conditions frequently cause conduction abnormalities, which may be the presenting or only feature.
- The myocardium may also be involved in inflammatory and autoimmune diseases.
The heart may be involved in a number of systemic syndromes. Many of these have been mentioned briefly in prior subsections of this chapter. The pericardium, myocardium, heart valves, and coronary arteries may be involved either singly or in various combinations. In most cases the cardiac manifestations are not the dominant feature, but in some it is the primary cause of symptoms and may be fatal.
The most common type of myocardial involvement is an infiltrative cardiomyopathy, such as systemic amyloidosis, sarcoidosis, hemochromatosis, or glycogen storage disease. Cardiac calcinosis can occur in hyperparathyroidism (usually the secondary form) and in primary oxalosis. A number of muscular dystrophies can cause a cardiomyopathic picture (particularly Duchenne's, less frequently myotonic dystrophy, and several rarer forms).
In addition to left ventricular dysfunction and heart failure, all of these conditions frequently cause conduction abnormalities, which may be the presenting or only feature.
The myocardium may also be involved in inflammatory and autoimmune diseases. It is commonly affected in polymyositis and dermatomyositis, but usually this is subclinical. Systemic lupus erythematosus, scleroderma, and mixed connective tissue disease may cause myocarditis, but these commonly also involve the pericardium, coronary arteries, or valves. Several endocrinopathies, including acromegaly, thyrotoxicosis, myxedema, and pheochromocytoma, can produce cardiomyopathies, though again they are usually not isolated features.
Pericardial involvement is quite common in many of the connective tissue diseases. Systemic lupus erythematosus may present with pericarditis, and pericardial involvement is not uncommon (but is less frequently symptomatic) in active rheumatoid arthritis, systemic sclerosis, and mixed connective tissue disease. Endocardial involvement takes the form of patchy fibrous - predominantly on the right side - or inflammatory or sclerotic changes of the heart valves. Carcinoid heart disease typically is manifested as tricuspid regurgitation, and the same may be the case in systemic lupus erythematosus. The hypereosinophilic syndromes involve the endocardium, leading to restrictive cardiomyopathy. A variety of arthritic syndromes are associated with aortic valvulitis or aortitis, including ankylosing spondylitis, rheumatoid arthritis, and Reiter's syndrome, as is tertiary syphilis also. Disorders of elastic tissue (Marfan's syndrome is the most frequent) often affect the ascending aorta, with resulting aneurysmal dilation and aortic regurgitation.
Almost any vasculitic syndrome can involve the coronary arteries, leading to myocardial infarction. This is most common with polyarteritis nodosa and systemic lupus erythematosus. Two vasculitic syndromes have a particular predilection for the coronary arteries - Kawasaki's disease and Takayasu's disease. In these, myocardial infarction may be the presenting symptom.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsMaking the business case for cardiac rehab programs
You know the saying: an ounce of prevention is worth a pound of cure. When it comes to cardiac rehabilitation, a study presented today at the Canadian Cardiovascular Congress has the numbers to prove it. "We found that…
17 October 2013
NewsEndocrinologists Not Surprised by Cardiac Studies
Study results showing two DPP-4 inhibitors neither increased nor decreased the risk of cardiovascular events in type 2 diabetes patients came as no surprise to endocrinologists contacted by MedPage Today. Both…
5 September 2013
NewsOut-of-hospital cardiac arrest survival just 7 percent
Sunday 1 September 2013: Survival for out-of-hospital cardiac arrest is just 7%, according to research presented at ESC Congress 2013 by Professor Xavier Jouven and Dr Wulfran Bougouin from France. Professor Jouven…
3 September 2013



